Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found three records

$4,575.00

Sep 7, 2025

For-profit organization

Agreement:

Syng Pharmaceuticals Inc.-2025-2026-1036923

Agreement Number:

1036923

Duration: from Sep 7, 2025 to Mar 31, 2026
Description:

The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.

Organization: National Research Council Canada
Program Name: CanExport Innovation
Location: Kingston, Ontario, CA K7P0L5

$0.00

Oct 2, 2017

For-profit organization

Agreement:

Development of first in vitro diagnostic kit for Endometriosis

Agreement Number:

893052

Duration: from Oct 2, 2017 to Jun 30, 2018
Description:

SYNG Pharma is developing first, in vitro test for endometriosis. This project will validate analytical methods for antigen antibody detection using different matrices, development of lateral flow device and generate new IP for detection of a new biomarker for endometriosis.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Kingston, Ontario, CA K7P 2A4

$33,900.00

Sep 6, 2017
Organization: National Research Council Canada
Location: Kingston, Ontario, CA